SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-22-000204
Filing Date
2022-03-03
Accepted
2022-03-03 16:37:55
Documents
12
Period of Report
2022-02-28
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opgen_8k.htm   iXBRL 8-K 23568
  Complete submission text file 0001079973-22-000204.txt   195452

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE opgn-20220228.xsd EX-101.SCH 3027
3 XBRL LABEL FILE opgn-20220228_lab.xml EX-101.LAB 34476
4 XBRL PRESENTATION FILE opgn-20220228_pre.xml EX-101.PRE 22591
6 EXTRACTED XBRL INSTANCE DOCUMENT opgen_8k_htm.xml XML 3565
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 240-813-1260
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 22709548
SIC: 8071 Services-Medical Laboratories